Jeannine Denholm
Showing of 79 results
University Hospitals Seidman Cancer Center Receives Funding to Implement Improved Symptom Monitoring for Patients Undergoing Cancer Treatment
University Hospitals Seidman Cancer Center Receives Funding to Implement Improved Symptom Monitoring for Patients Undergoing Cancer Treatment.
UH Seidman Cancer Center Researcher Awarded New Gastrointestinal Cancer Grant from NCCN in Collaboration with Taiho Oncology, Inc.
Dr. Madison Conces was awarded for a Phase II Clinical Trial of Trifluridine/Tipiracil plus Oxaliplatin in Patients with Advanced or Metastatic Biliary Tract Cancer Following First-Line Therapy.
Research Team from Wesley Center for Immunotherapy at UH Seidman Cancer Center Awarded Top Scoring Abstract Award at the 2025 International Society for Cell and Gene Therapy Annual Meeting
Dr. David Wald and his colleagues selected for their abstract "Development and Clinical Validation of a Less Than One Day CAR T-cell Therapy Manufacturing Process".
Cholesterol Drug Repurposed as Investigational Therapy for HPV+ Cancers at University Hospitals Seidman Cancer Center in Nation’s First-Ever Clinical Trials
UH Seidman Cancer Center will soon begin to look into the use of fenofibrate as a potential treatment for HPV+ cancers.
University Hospitals Seidman Cancer Center is one of the first in North America to offer Varian Ethos 2.0 for cancer patients
The radiation treatment allows for unprecedented targeting of tumors while sparing healthy organs in almost a dozen different types of cancer.
University Hospitals Urology Institute Awarded $9.2 Million by the Patient Centered Outcomes Research Institute
Study will compare bulking versus sling for treating urinary incontinence at the time of vaginal prolapse repair.
Phase 1 BAFF CAR T Clinical Trial for Patients with Relapsed and Refractory Multiple Myeloma Underway at UH Seidman Cancer Center
Study is being done through an agreement between UH and Luminary Therapeutics.
UH Seidman Cancer Center Offers Patients Rare Access to New Kidney Cancer Tracer
UH Seidman Cancer Center is one of just a few cancer centers nationwide to offer its patients early access to a novel and more sensitive method of diagnosing kidney cancer.